Developing Next-Generation Biopharmaceuticals

R&D Center

Our research is focused on developing various long-acting microsphere injectables based on InnoLAMP technology:

Long-acting pharmaceutical formulation research, analytical studies, and production process studies for various APIs. For each target drug, we have successfully developed optimized release duration and its profiles and commercial production processes as well.

GMP Facility

G2GBIO possesses its own GMP-compliant facility.

It is inside the building of KBIO Health located in Osong, Chungcheongbuk-do. This facility is capable of manufacturing pharmaceutical products in clinical trials or at early stages of commercialization.